Connection
Gregory Schwartz to Liver Cirrhosis
This is a "connection" page, showing publications Gregory Schwartz has written about Liver Cirrhosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.044 |
|
|
|
-
Grobbee EJ, de Jong VD, Schrieks IC, Tushuizen ME, Holleboom AG, Tardif JC, Lincoff AM, Schwartz GG, Castro Cabezas M, Grobbee DE. Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-a/? agonist aleglitazar. PLoS One. 2022; 17(11):e0277706.
Score: 0.044